Prelude Capital Management, LLC Cel Sci Corp Put Options Transaction History

Prelude Capital Management, LLC

  • $1.39 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2020

May 15, 2020
SELL
$7.54 - $17.05 $34,684 - $78,430
-4,600 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$6.71 - $9.55 $30,866 - $43,930
4,600 New
4,600 $42,000
Q3 2019

Nov 14, 2019
SELL
$6.0 - $9.6 $20,400 - $32,640
-3,400 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$3.77 - $8.67 $12,818 - $29,478
3,400 New
3,400 $28,000

Others Institutions Holding CVM

# of Institutions
71
Shares Held
6.16M
Call Options Held
16.6K
Put Options Held
148K
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $47.7M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email